Skip to main content
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.49
+0.18 (1.59%)
Nov 20, 2024, 4:00 PM EST - Market closed

Roivant Sciences Revenue

Roivant Sciences had revenue of $4.48M in the quarter ending September 30, 2024, with 22.67% growth. This brings the company's revenue in the last twelve months to $129.13M, up 145.68% year-over-year. In the fiscal year ending March 31, 2024, Roivant Sciences had annual revenue of $124.80M with 103.65% growth.

Revenue (ttm)
$129.13M
Revenue Growth
+145.68%
P/S Ratio
68.40
Revenue / Employee
$142,213
Employees
908
Market Cap
8.36B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024124.80M63.52M103.65%
Mar 31, 202361.28M5.99M10.84%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 202067.69M65.37M2,812.61%
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Walgreens Boots Alliance 147.66B
Grifols 7.81B
The Ensign Group 4.11B
Bruker 3.24B
Chemed 2.38B
Masimo 2.04B
Tempus AI 640.44M
Intra-Cellular Therapies 613.73M
Revenue Rankings

ROIV News

More News